D.J. St. Germain’s bluebird bio BLUE Stock Holding History

D.J. St. Germain’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$10	–	886
2025 Q1	$10	Hold	2	–	–	﹤0.01%	799
2024 Q4	$17	Sell	2 -1	-33%	-$9	﹤0.01%	825
2024 Q3	$30	Hold	3	–	–	﹤0.01%	764
2024 Q2	$56	Hold	3	–	–	﹤0.01%	762
2024 Q1	$73	Hold	3	–	–	﹤0.01%	768
2023 Q4	$79	Hold	3	–	–	﹤0.01%	766
2023 Q3	$173	Hold	3	–	–	﹤0.01%	734
2023 Q2	$188	Buy	+3	New	+$219	﹤0.01%	703

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.J. St. Germain's BLUE Position: Q2 2025 in Review

D.J. St. Germain sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 2 shares — an estimated $10 sold.

D.J. St. Germain first reported a position in BLUE in Q2 2023 and held it in 8 quarters. The position peaked at $188 in Q2 2023. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

D.J. St. Germain reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
D.J. St. Germain sold 2 bluebird bio shares in Q2 2025, an estimated $10.
D.J. St. Germain first reported a position in bluebird bio in Q2 2023 and held it in 8 quarters.
D.J. St. Germain's bluebird bio position peaked at $188 in Q2 2023.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on D.J. St. Germain's 13F filing for Q2 2025, filed 16 Jul 2025.